Inkon Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 28, 2021 at 12:35 pm
Share
INKON Life Technology Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 132.529 million compared to CNY 100.274 million a year ago. Operating income was CNY 21.954 million compared to operating loss of CNY 9.645 million a year ago. Net income was CNY 11.473 million compared to net loss of CNY 11.712 million a year ago. Basic earnings per share from continuing operations was CNY 0.0179 compared to basic loss per share from continuing operations of CNY 0.0215 a year ago.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
INKON LIFE TECHNOLOGY CO., LTD. 
